DTM vs IONS · P/E 28, rev $981.0M vs rev $226.6M
DT Midstream Inc (DTM) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
DT Midstream Inc (DTM) is a oil & gas midstream company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported DTM revenue for 2024-12-31 was $981.0M. Net income was $367.0M. Revenue was up 6.4% from 2023-12-31 to 2024-12-31. DTM currently screens at market cap $10.44B and trailing P/E 28.0.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
DTM currently screens at market cap $10.44B and trailing P/E 28.0. IONS currently screens at market cap $12.28B.
Not investment advice. Open the DTM and IONS stock pages for the full models.
Not investment advice.